截至1月25日，北交所已有8家上市公司率先披露了2025年度业绩预告。其中，5家净利润预增，1家净利 润预降，2家预亏。整体来看，业绩预告传递出积极信号，多数公司预计盈利实现增长。这反映出部分 北交所公司正抓住市场机遇，提升自身竞争力；同时，也有企业仍面临成本上升、行业调整等挑战，业 绩阶段性承压。 业绩整体向好 从已披露的8份业绩预告来看，北交所公司2025年的经营成绩单初步呈现出分化态势。其中，业绩预喜 的公司占据主流，共有五家。海能技术预计归母净利润实现翻倍以上增长，增幅高达213.65%至 236.61%。吉林碳谷同样表现亮眼，净利润预计达到1.8亿元至2.2亿元，同比增长92.81%至135.66%。龙 竹科技、旺成科技和林泰新材也分别预计净利润有约50%、超过66%和超过64%的增长，显示出稳健或 强劲的增长势头。 市场需求回暖 然而，也有三家公司的业绩预告不尽如人意。华岭股份预计将出现亏损，净利润为亏损4400万元至5600 万元，亏损幅度同比扩大。另一家颖泰生物虽然预计净利润仍为亏损2亿元至2.6亿元，但相较上年同期 的巨额亏损，幅度已大幅收窄，呈现复苏迹象。戈碧迦则预告净利润同比下降，预计下 ...

然而，也有三家公司的业绩预告不尽如人意。华岭股份预计将出现亏损，净利润为亏损4400万元至 5600万元，亏损幅度同比扩大。另一家颖泰生物虽然预计净利润仍为亏损2亿元至2.6亿元，但相较上年 同期的巨额亏损，幅度已大幅收窄，呈现复苏迹象。戈碧迦则预告净利润同比下降，预计下降幅度为 59.63%。整体来看，这八家公司的业绩表现与所属行业的景气度、自身经营策略的执行效果密切相 关，反映了北交所上市公司在不同赛道上的差异化发展现状。 市场需求回暖 分析业绩预增公司的公告内容可以看出，其增长动力主要源于外部市场环境改善与内部能力提升的 双重驱动。 行业需求的整体回暖是重要背景。例如，海能技术明确提到，行业市场需求整体回暖，高端仪器国 产制造趋势显著，且设备更新政策逐步落地，为其在新材料、新能源等领域的增长创造了条件。吉林碳 谷也指出，随着碳纤维市场逐步回暖，公司产品销量实现持续增长。 更重要的是，这些公司普遍通过持续的技术创新、产品升级和市场开拓，强化了内生增长动能。 海能技术近年来持续投入研发，推出了有机元素分析仪、液相色谱仪等高端产品，并在智能化、数 字化方面取得进展，从而提升了客户认可度和产品收入。吉林碳谷通过 ...

业绩整体向好 从已披露的8份业绩预告来看，北交所公司2025年的经营成绩单初步呈现出分化态势。其中，业绩预喜 的公司占据主流，共有五家。海能技术预计归母净利润实现翻倍以上增长，增幅高达213.65%至 236.61%。吉林碳谷同样表现亮眼，净利润预计达到1.8亿元至2.2亿元，同比增长92.81%至135.66%。龙 竹科技、旺成科技和林泰新材也分别预计净利润有约50%、超过66%和超过64%的增长，显示出稳健或 强劲的增长势头。 海能技术预计归母净利润实现翻倍以上增长，增幅高达213.65%至236.61%。吉林碳谷同样表现亮眼， 净利润预计达到1.8亿元至2.2亿元，同比增长92.81%至135.66%。龙竹科技、旺成科技和林泰新材也分 别预计净利润有约50%、超过66%和超过64%的增长。 ● 本报记者杨梓岩 截至1月25日，北交所已有8家上市公司率先披露了2025年度业绩预告。其中，5家净利润预增，1家净利 润预降，2家预亏。整体来看，业绩预告传递出积极信号，多数公司预计盈利实现增长。这反映出部分 北交所公司正抓住市场机遇，提升自身竞争力；同时，也有企业仍面临成本上升、行业调整等挑战，业 绩阶段性承压 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected performance that will exceed the market by over 20% [4]. Core Insights - The company forecasts a significant increase in net profit attributable to shareholders for 2025, estimated between 41 to 44 million yuan, representing a year-on-year growth of approximately 213.65% to 236.61% [1]. - The expected operating revenue for 2025 is around 362 million yuan, reflecting a year-on-year increase of about 16.77% [1]. - The company is actively investing in high-end instruments and has made progress in their smart and digital capabilities, with new products like organic element analyzers and liquid chromatography instruments gaining market recognition [2]. - The company has received multiple invention patents, enhancing its intellectual property moat and supporting future product iterations and market expansion [3]. Financial Summary - The projected financial metrics for the company are as follows: - Operating revenue (million yuan): 341 in 2023, 310 in 2024, 362 in 2025, 435 in 2026, and 499 in 2027, with a year-on-year growth of 18.7% in 2023, -9.1% in 2024, and 16.7% in 2025 [6]. - Net profit attributable to shareholders (million yuan): 45 in 2023, 13 in 2024, 43 in 2025, 53 in 2026, and 64 in 2027, with a year-on-year growth of 1.4% in 2023, -71.0% in 2024, and 225.7% in 2025 [6]. - Earnings per share (EPS): 0.53 in 2023, 0.15 in 2024, 0.50 in 2025, 0.62 in 2026, and 0.75 in 2027 [6]. - Price-to-earnings ratio (P/E): 48.3 in 2023, 166.5 in 2024, 51.1 in 2025, 41.0 in 2026, and 33.9 in 2027 [6].

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 今日，海能未来发布业绩预告公告： 海能未来技术集团股份有限公司2025年年度业绩预告公告 特别提示：本公告所载2025年年度主要财务数据为初步核算数据，未经会计师事务所审计，具体数据以公司2025年年度报告中披露的数 据为准，提请投 资者注意投资风险。 一、本期业绩预告情况 (一)业绩预告期间 2025 年1月1日至2025年12月31日。 (二)业绩预告情况 √年度实现盈利，且净利润与上年同期相比上升50%以上 213.65%～236.61%报告期内，预计归属于上市公司股东的净利润同比大幅增长，主要原因系： 1、报告期内，行业市场需求整体回暖，高端仪器国产制造趋势显著、设备更新政策逐步落地，公司在新材料、新能源、制药等领域增长 较快。报告期内， 预计实现营业收入约3.62亿元，同比增长约16.77%，各系列产品收入均实现增长。 2、公司基于对行业长期发展的信心，近年来在产品研发、市场拓展、品牌提升等方面保持持续投入，推出了有机元素分析仪、液相色谱 仪等高端仪器产品，在高端仪器智能化、数字化方 ...

摘要 ：2026已经开启，回顾2025年，哪些有机元素分析仪持续获得用户的重点关注？仪器信息网对所 有在展品牌的有机元素分析仪产品的年度浏览量进行了统计，正式发布"2025年热度榜单" 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 有 机 元 素 分 析 仪 作 为 一 种 实 验 室 常 规 仪 器 ， 可 同 时 对 有 机 的 固 体 、 高 挥 发 性 和 敏 感 性 物 质 中 C、H、N、S、元素的含量进行定量分析测定, 在研究有机材料及有机化合物的元素组成等方 面具有重要作用。可广泛应用于化学和药物学产品，如精细化工产品、药物、肥料、石油化工 产品碳、氢、氧、氮元素含量，从而揭示化合物性质变化，得到有用信息，是科学研究的有效 手段。 2026已经开启，回顾2025年，哪些有机元素分析仪持续获得用户的重点关注？仪器信息网对 所有在展品牌的有机元素分析仪产品的年度浏览量进行了统计，正式发布"2025年元素分析仪 热度榜单"，详情如下： 有机元素分析仪2025年度用户关注热度榜单TOP10 | 仪器 | 品牌 | | --- | ...

Core Viewpoint - The article highlights the rebranding of Elementar China as part of its localization strategy to enhance its market presence and drive high-quality development in China [1][2][3]. Group 1: Company Rebranding - Elementar China has officially changed its name from "艾力蒙塔贸易（上海）有限公司" to "艾力蒙塔分析仪器（上海）有限公司" to reflect its commitment to localization and strategic upgrade [2][3]. - The rebranding signifies a new phase for the company, marking the initiation of a comprehensive localization strategy aimed at sustainable growth in the competitive Chinese market [2][3]. Group 2: Company Background - Elementar is a global leader in high-performance organic and inorganic element analysis, with over 120 years of expertise since its establishment in 1897 [6][7]. - The company focuses on continuous innovation and customized solutions, offering a range of products including organic element analyzers, TOC analyzers, and isotope ratio mass spectrometers, serving clients across various scientific fields [6][7].

Investment Rating - The report maintains an "Outperform" rating for the company [7]. Core Views - The company reported strong growth in its 2025 half-year results, with revenue reaching 136 million yuan, a year-on-year increase of 34.9%, and a net profit of 5 million yuan, up 139.0% year-on-year [4][7]. - The growth is driven by all four major product lines, particularly the "Spectroscopy Series," which saw a revenue increase of 61.7% [7]. - The company is expected to benefit from ongoing equipment replacement demands and favorable industry conditions, particularly in the spectroscopy segment, which is anticipated to become a new growth engine [7]. Financial Data and Profit Forecast - The company’s total revenue is projected to be 378 million yuan in 2025, with a year-on-year growth rate of 21.9% [6]. - The net profit forecast for 2025 is 51 million yuan, reflecting a significant increase of 290.8% compared to the previous year [6]. - The gross profit margin is expected to improve to 66.8% by 2025, indicating a positive trend in profitability [6]. Revenue and Profit Analysis - In the first half of 2025, the company achieved a gross profit margin of 63.6%, an increase of 0.9 percentage points year-on-year [7]. - The company has successfully reduced its expense ratios, with significant decreases in sales, management, and R&D expense ratios [7]. - The company is focusing on expanding its enterprise customer base, which now accounts for over 50% of its revenue, enhancing its operational resilience [7].

Summary of Key Points from the Conference Call Company Overview - **Company**: Haineng Technology - **Industry**: Scientific Instruments Core Insights and Arguments 1. **Revenue Growth**: Haineng Technology reported over 35% revenue growth in the first half of 2025, with Q2 revenue exceeding 81 million yuan, showing a year-on-year increase of over 30% and a quarter-on-quarter increase of over 40% [2][5][6] 2. **Profit Increase**: The company achieved a profit increase of nearly 20 million yuan in the first half of 2025, attributed to over 15% R&D investment over the past three years, enhancing product competitiveness and reliability [2][7] 3. **Market Share**: Despite a challenging industry environment in 2024, Haineng maintained market and sales investments, increasing market share in various segments, with enterprise clients accounting for nearly 50% of its customer base [2][8] 4. **Performance vs. Industry**: Haineng's 30% performance growth in the first half of 2025 significantly outpaced the industry average, with a ten-year compound growth rate close to 20% [2][9] 5. **Domestic Production Rate**: The domestic production rate of Haineng's liquid chromatography instruments reached 70%, with some core components achieving a general level of production, although challenges remain in ultra-high-performance liquid chromatography [2][12][22] 6. **Shareholder Returns**: The company has actively engaged in stock buybacks and dividends, having distributed dividends at least four times in the past five years, with plans to continue this strategy to enhance investor confidence [2][37][38] Additional Important Insights 1. **Industry Trends**: The scientific instruments industry is experiencing a recovery, particularly in investments from universities and research institutions, although large-scale projects have yet to materialize [10][11] 2. **Domestic Substitution Progress**: The trend towards domestic substitution in the scientific instruments sector has accelerated, with Haineng's products receiving positive feedback and gaining market share against imported brands [12][14] 3. **Future Outlook**: The company anticipates that the successful implementation of large-scale equipment renewal projects will be a key factor influencing future growth, despite delays in order placements [10][11] 4. **Product Development**: Haineng is focusing on expanding its product lines, including the introduction of new products like "Bai Xiaobai," which is currently in the market introduction phase [2][26] 5. **International Market Expansion**: Haineng's overseas revenue exceeded 10 million USD for the first time, accounting for about 20% of total revenue, with plans for further international market expansion [18][35] Conclusion Haineng Technology is positioned for robust growth in the scientific instruments industry, driven by significant revenue and profit increases, strategic investments in R&D, and a focus on domestic production and international expansion. The company's proactive approach to shareholder returns and market share enhancement further solidifies its competitive stance in the industry.

Investment Rating - The report maintains an "Outperform" rating for the company [2] Core Insights - The company reported a revenue of 310 million yuan in 2024, a decrease of 9.1% year-on-year, and a net profit of 13 million yuan, down 71.0% year-on-year, which was below expectations [7] - In Q1 2025, the company achieved a revenue of 55 million yuan, an increase of 37.8% year-on-year, although it reported a net loss of 1 million yuan [7] - The company is expected to benefit from government policies aimed at promoting equipment updates and increasing technology spending, which could lead to a recovery in demand [7][10] Financial Data and Profit Forecast - The company’s total revenue is projected to be 342 million yuan in 2025, with a year-on-year growth rate of 10.2% [6] - The net profit forecast for 2025 is 43 million yuan, representing a significant increase of 230.5% compared to 2024 [6] - The company’s gross margin is expected to be 65.6% in 2025, slightly improving from 64.3% in Q1 2025 [6] Revenue Breakdown - In 2024, the company’s revenue from organic element analysis was 104 million yuan, down 23.0% year-on-year, while sample preparation revenue was 57 million yuan, down 18.7% [7] - The chromatography and spectroscopy segment generated 79 million yuan, with liquid chromatography instruments contributing 46 million yuan, an increase of 27.2% year-on-year [7] - The company’s international revenue reached 70 million yuan in 2024, up 12.2% year-on-year, driven by expanded overseas distribution channels [7] Strategic Initiatives - The company has been investing in automation and digitalization since 2014, enhancing its manufacturing capabilities [10] - The introduction of a digital core platform in 2024 is expected to support the production of customized non-standard components [10] - The report highlights the company’s proactive approach in recruiting high-quality talent during industry downturns to ensure long-term growth [7][10]